Glioblastoma Organoids: Pre-Clinical Applications and Challenges in the Context of Immunotherapy

Malignant brain tumors remain uniformly fatal, even with the best-to-date treatment. For Glioblastoma (GBM), the most severe form of brain cancer in adults, the median overall survival is roughly over a year. New therapeutic options are urgently needed, yet recent clinical trials in the field have b...

Descripción completa

Detalles Bibliográficos
Autores principales: Klein, Eliane, Hau, Ann-Christin, Oudin, Anaïs, Golebiewska, Anna, Niclou, Simone P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7753120/
https://www.ncbi.nlm.nih.gov/pubmed/33364198
http://dx.doi.org/10.3389/fonc.2020.604121

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7753120/
https://www.ncbi.nlm.nih.gov/pubmed/33364198
http://dx.doi.org/10.3389/fonc.2020.604121

Ejemplares similares